Mycobacterium tuberculosis infection in psoriatic patients treated with biologics: Real‐world data from 18 Japanese facilities-Reference-Cited by-同舟云学术

Mycobacterium tuberculosis infection in psoriatic patients treated with biologics: Real‐world data from 18 Japanese facilities

Published:2019-11-24 Issue:2 Volume:47 Page:128-132
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Kaneko Sakae¹^ORCID,Tsuruta Noriko²³^ORCID,Yamaguchi Kazuki²,Miyagi Takuya⁴,Takahashi Kenzo⁴,Higashi Yuko⁵^ORCID,Morizane Shin⁶^ORCID,Nomura Hayato⁶,Yamaguchi Michiya⁷,Hino Ryosuke⁸⁹,Sawada Yu⁹^ORCID,Nakamura Motonobu⁹,Ohyama Bungo¹⁰,Ohata Chika¹⁰^ORCID,Yonekura Kentaro¹¹,Hayashi Hiroaki¹²,Yanase Tetsuji¹³,Matsuzaka Yuki¹⁴,Sugita Kazunari¹⁵,Kikuchi Satoko¹⁶,Mitoma Chikage¹⁷^ORCID,Nakahara Takeshi¹⁷^ORCID,Furue Masutaka¹⁷^ORCID,Okazaki Fusako¹⁸,Koike Yuta¹⁹^ORCID,Imafuku Shinichi²^ORCID,

Affiliation:

1. Department of Dermatology Shimane University Faculty of Medicine IzumoJapan

2. Department of Dermatology Fukuoka University Faculty of Medicine Fukuoka Japan

3. Division of Dermatology Department of Internal Medicine Faculty of Medicine Saga University Saga Japan

4. Department of Dermatology Graduate School of Medicine University of the Ryukyus University of the Ryukyus Nishihara Japan

5. Department of Dermatology Kagoshima University Graduate School of Medical and Dental Sciences Kagoshima Japan

6. Department of Dermatology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

7. Department of Dermatology Yamaguchi University Graduate School of Medicine Ube Japan

8. Hino Dermatology Clinic Fukutsu Japan

9. Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan

10. Department of Dermatology Kurume University School of Medicine Kurume Japan

11. Department of Dermatology Imamura General Hospital Kagoshima Japan

12. Department of Dermatology Kawasaki Medical School Okayama Japan

13. Department of Dermatology Hiroshima City Asa Citizens Hospital Hiroshima Japan

14. Department of Dermatology Onomichi General Hospital Onomichi Japan

15. Division of Dermatology Department of Medicine of Sensory and Motor Organs Tottori University Faculty of Medicine Yonago Japan

16. Department of Dermatology Kyushu Central Hospital Fukuoka Japan

17. Department of Dermatology Graduate School of Medical Sciences Kyushu University Fukuoka Japan

18. Department of Dermatology Fukuyama City Hospital Fukuyama Japan

19. Department of Dermatology Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15156

Reference22 articles.

1. World Health Organization.Global tuberculosis Report 2018. [Cited 10 Dec 2018.] Available from URL:http://www.who.int/tb/publications/global_report/en/.

2. Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

3. Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

4. Recall of long‐lived immunity to Mycobacterium tuberculosis infection in mice;Andersen P;J Immunol,1995

5. A Mycobacterium tuberculosis operon encoding ESAT=6 and a novel low-molecular-mass culture filtrate protein (CFP-10)

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic therapy for psoriasis and the risk of cutaneous infections;The Journal of Dermatology;2024-04-25

2. Active Tuberculosis in a Patient Receiving Adalimumab for Psoriatic Arthritis and Chemoprophylaxis for Latent Tuberculosis Infection;Journal of Nippon Medical School;2023-12-25

3. Survival rates of systemic interventions for psoriasis in the Western Japan Psoriasis Registry: A multicenter retrospective study;The Journal of Dermatology;2023-02-14

4. Clinical characteristics of patients with psoriasis with family history: A multicenter observational study;The Journal of Dermatology;2023-01-24

5. The Tuberculosis Positive Conversion Rate Among Psoriasis Patients Treated with Adalimumab and Secukinumab: A Single-Center Retrospective Study in China;Dermatology and Therapy;2022-05-26